Overview

• Hims & Hers has introduced Eli Lilly's Zepbound and Mounjaro, as well as generic liraglutide, to its telehealth weight-loss platform.
• Zepbound and Mounjaro are priced at $1,899 per month, while the generic liraglutide is offered at $299 per month, targeting more cost-sensitive customers.
• Eli Lilly clarified it has no partnership with Hims & Hers, countering initial market confusion following the announcement.
• Investor enthusiasm waned after the announcement, with concerns over the high cost of branded drugs and the revenue potential of the offerings.
• The company is focusing on expanding its weight-loss program with personalized features and continues lobbying for access to compounded medications despite FDA restrictions.